Author: Fung, To Sing; Liu, Ding Xiang
Title: Post-translational modifications of coronavirus proteins: roles and function Document date: 2018_5_21
ID: 38c28tw1_37
Snippet: Coronavirus nsp16 has been identified as a nucleoside-2 O-methyltransferase (2 -O-MTase) [156] . By modifying the cap-0 structure at the ribose 2 -O position of the first nucleotide to form cap-1 structures, nsp16 enables the viral RNA to avoid detection by the cytoplasmic pattern recognition receptor MDA5. In fact, compared with wild-type control, recombinant virus lacking the nsp16 2 -O-MTase activity induced a high level of type I interferon i.....
Document: Coronavirus nsp16 has been identified as a nucleoside-2 O-methyltransferase (2 -O-MTase) [156] . By modifying the cap-0 structure at the ribose 2 -O position of the first nucleotide to form cap-1 structures, nsp16 enables the viral RNA to avoid detection by the cytoplasmic pattern recognition receptor MDA5. In fact, compared with wild-type control, recombinant virus lacking the nsp16 2 -O-MTase activity induced a high level of type I interferon in the infected cells, and viral replication was highly sensitive to the antiviral function of exogenous interferon [157] . Using yeast two-hybrid screening, a component of E3 ubiquitin ligase -von Hippel Lindau (VHL) was found to interact with SARS-CoV nsp16 [158] . Overexpression of VHL promoted the ubiquitin-proteasomal degradation of SARS-CoV nsp16, while knockdown of VHL increased the protein stability of nsp16 [158] . However, the precise ubiquitination site in SARS-CoV nsp16 has not been mapped, and similar modifications of nsp16 in other coronaviruses have not been characterized. Also, the physiological significance of nsp16 ubiquitination remains to be investigated using recombinant viruses under the setting of actual coronavirus infection.
Search related documents:
Co phrase search for related documents- protein stability and structure form: 1, 2
- recombinant virus and structure form: 1, 2
- recombinant virus and ubiquitin ligase: 1
- recombinant virus and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- recombinant virus and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- recombinant virus and wild type control: 1, 2, 3, 4, 5, 6
- recombinant virus and yeast hybrid screening: 1
- similar modification and viral replication: 1
- similar modification and wild type: 1
- structure form and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- structure form and wild type: 1, 2, 3, 4, 5
- structure modify and viral replication: 1
- ubiquitin ligase and viral replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- ubiquitin ligase and wild type: 1, 2, 3, 4, 5, 6, 7, 8
- ubiquitin proteasomal degradation and viral replication: 1, 2
- ubiquitin proteasomal degradation and wild type: 1, 2
- viral replication and wild type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- viral replication and wild type control: 1, 2, 3, 4, 5
- viral replication and yeast hybrid screening: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date